FDA Initiates Review of BHA, a Common Food Preservative
The U.S. Food and Drug Administration has announced that it is launching a safety assessment of butylated hydroxyanisole (BHA), a synthetic antioxidant widely used in food products to prevent rancidity in fats and oils.
BHA has been authorized for use in food for decades within established regulatory limits. FDA stated that this review is part of its broader initiative to reassess food chemicals using updated scientific methodologies and current exposure data.
What This Assessment Involves
According to the Agency, the evaluation will consider:
- Existing toxicological data
- Estimated dietary exposure levels
- New scientific literature
- Current approved conditions of use
At this time, FDA has not proposed changes to BHA’s regulatory status. The announcement reflects an evaluation process rather than a determination of risk.
Context Within FDA’s Modernization Efforts
FDA has recently signaled increased focus on reviewing legacy food additives and preservatives under updated risk assessment frameworks. The reassessment of BHA aligns with this broader effort to ensure that existing authorizations continue to meet contemporary scientific standards.
Considerations for Food Manufacturers
- Confirm usage remains within regulatory limits
- Maintain current safety documentation and supplier certifications
- Monitor FDA communications for potential updates
- Consider long-term formulation planning if future changes are proposed
Source: FDA News Release
Date: February 10, 2026
Posted in FDA and USDA Regulatory Update, Foods.